Unknown

Dataset Information

0

Radiopharmaceutical Formulation and Preclinical Testing of 68Ga-Labeled DOTA-MGS5 for the Regulatory Approval of a First Exploratory Clinical Trial.


ABSTRACT: The new minigastrin analog DOTA-MGS5 is a promising new candidate for targeting cholecystokinin-2 receptor (CCK2R)-expressing tumors. To enable the clinical translation of PET/CT imaging using 68Ga-labeled DOTA-MGS5, different quality and safety aspects need to be considered to comply with the regulatory framework for clinical trial application. The preparation of the radiopharmaceutical was established using a cassette-based automated synthesis unit. Product specifications, including analytical procedures and acceptance criteria, were adopted from Ph. Eur. monographs for other 68Ga-labeled radiopharmaceuticals. Non-clinical studies included receptor affinity and cell uptake studies using two different CCK2R-expressing cell lines, as well as pharmacokinetic biodistribution studies in BALB/c mice for dosimetry calculations and toxicological studies in Wistar rats. The produced masterbatches fulfilled the defined acceptance criteria. DOTA-MGS5, with confirmed affinity to the CCK2R, showed a high specific cell uptake and no interaction with other receptors in vitro when radiolabeled with gallium-68. Favorable in vivo properties were observed in biodistribution and dosimetry studies. An effective dose of ~0.01 mSv/MBq was estimated for humans utilizing OLINDA/EXM software. A maximum peptide dose of 50 µg was established for the initial clinical dose based on the toxicity study in rats. The standardized production of [68Ga]Ga-DOTA-MGS5 using an automated synthesis module and the performed non-clinical safety studies support a first exploratory clinical trial with this new PET imaging agent.

SUBMITTER: Hormann AA 

PROVIDER: S-EPMC8235783 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8949806 | biostudies-literature
| S-EPMC5290997 | biostudies-literature
| S-EPMC5381245 | biostudies-literature
| S-EPMC9954147 | biostudies-literature
| S-EPMC8761874 | biostudies-literature
| S-EPMC9078465 | biostudies-literature
| S-EPMC8994000 | biostudies-literature
| S-EPMC9617990 | biostudies-literature
| S-EPMC6401503 | biostudies-literature
| S-EPMC9157726 | biostudies-literature